Stimulate innovation in clinical evaluations and personalized medicine to improve product development and patient outcomes.
Ended Definitive Contract Awarded Last action
- Contract number
- 75F40121C00138
- Awardee
-
Academisch Ziekenhuis Leiden UEI FBNPDEEAHHF4
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $1,042,116
Award facts
- Opportunity
-
- FY21 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science Solicitation · FDABAA2100123 · Posted Nov 20, 2020
- Contract value 100% obligated
- $1,042,116.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Basic Research
- Pricing
- Firm Fixed Price
- Place of performance
- Netherlands
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$7,884 | |
| Supplemental Agreement for work within scope | $350,000 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $700,000 |
About this award
The Food and Drug Administration awarded a $1.04M firm fixed-price definitive contract to Academisch Ziekenhuis Leiden (Leids Universitair Medisch Centrum) in the Netherlands to stimulate innovation in clinical evaluations and personalized medicine to improve product development and patient outcomes. The contract, awarded on September 23, 2021, was issued under the FDA's Broad Agency Announcement for Advanced Regulatory Science, which seeks research and development proposals across multiple areas of regulatory science to modernize toxicology, support clinical innovation, and strengthen regulatory functions. This award represents the FDA's investment in external research capabilities to advance its regulatory science mission and supports the agency's ongoing efforts to modernize its scientific approach to product evaluation and approval.
The contract reached its ultimate completion date on September 29, 2024, and this modification serves to de-obligate remaining funds and close out the award. No small business set-aside designation was applied to this contract. Leids Universitair Medisch Centrum is a university medical center with demonstrated expertise in clinical research and personalized medicine, having previously supported FDA regulatory science initiatives and conducted research funded by the National Institutes of Health and other federal agencies across therapeutic areas including vaccine development, infectious disease immunity, and genetic research.
Quick answers
Who was awarded contract 75F40121C00138?
75F40121C00138 was awarded to Academisch Ziekenhuis Leiden by Food and Drug Administration (Department of Health and Human Services) on September 23, 2021.
How much is contract 75F40121C00138 worth?
The government has obligated $1,042,116 on 75F40121C00138.
Was contract 75F40121C00138 competed?
The extent of competition for 75F40121C00138 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award